Wang Chih-Chi, Iyer Shridhar G, Low Jee Keem, Lin Chih-Yun, Wang Shih-Ho, Lu Sen-Nan, Chen Chao-Long
Department of Surgery, Division of General Surgery, Liver Transplant Program, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Niao-Sung, Kaohsiung, Taiwan.
Ann Surg Oncol. 2009 Jul;16(7):1832-42. doi: 10.1245/s10434-009-0448-y. Epub 2009 Apr 14.
The aim of this study was to evaluate the long-term outcomes of liver resection for hepatocellular carcinoma (HCC).
Between January 1993 and December 2002, a total of 473 patients underwent hepatectomy for HCC at a medical center in Taiwan. Clinicopathological and surgical characteristics were studied to identify prognostic factors influencing survival.
There were 379 men (80.1%) with mean +/- standard deviation age of 53.1 +/- 13.1 years. The etiology of HCC was hepatitis B (n = 277), hepatitis C (n = 90), coinfection with hepatitis B and C (n = 47), and non-B or C hepatitis (n = 50). The blood loss was 282.3 +/- 370.5 ml, and 411 patients (86.9%) did not require perioperative blood transfusion. On univariate analysis, the statistically significant independent factors for disease-free survival were alfa-fetoprotein (AFP) levels of >400 ng/ml, indocyanine green retention of >10%, Pringle maneuver, blood transfusion, tumor diameter >5 cm, bilateral tumors, microvascular invasion, adjacent tissue invasion, daughter nodules and cirrhotic liver. The univariate factors influencing overall survival were similar to those influencing disease-free survival except for AFP. Independent factors that statistically significantly affected overall survival on multivariate analysis included Pringle maneuver, blood transfusion, tumor diameter >3 cm, microvascular invasion, daughter nodules, and liver cirrhosis. The 1-, 5-, and 10-year disease-free survival were 75.3, 43.3, and 22.3%, respectively. The 1-, 5-, and 10-year overall survival were 86.7, 55, and 33.7%, respectively.
AFP, indocyanine green retention of >10%, blood transfusion, Pringle maneuver, tumor diameter of >3 cm, bilateral tumors, microvascular invasion, adjacent tissue invasion, daughter nodules, and liver cirrhosis influence survival.
本研究的目的是评估肝细胞癌(HCC)肝切除的长期疗效。
1993年1月至2002年12月期间,台湾一家医疗中心共有473例患者因HCC接受了肝切除术。研究临床病理和手术特征以确定影响生存的预后因素。
有379名男性(80.1%),平均年龄±标准差为53.1±13.1岁。HCC的病因是乙型肝炎(n = 277)、丙型肝炎(n = 90)、乙型和丙型肝炎合并感染(n = 47)以及非乙或丙型肝炎(n = 50)。失血量为282.3±370.5毫升,411例患者(86.9%)围手术期无需输血。单因素分析显示,无病生存的统计学显著独立因素包括甲胎蛋白(AFP)水平>400 ng/ml、吲哚菁绿潴留>10%、Pringle手法、输血、肿瘤直径>5 cm、双侧肿瘤、微血管侵犯、邻近组织侵犯、子结节和肝硬化肝。影响总生存的单因素与影响无病生存的因素相似,但AFP除外。多因素分析中对总生存有统计学显著影响的独立因素包括Pringle手法、输血、肿瘤直径>3 cm、微血管侵犯、子结节和肝硬化。1年、5年和10年无病生存率分别为75.3%、43.3%和22.3%。1年、5年和10年总生存率分别为86.7%、55%和33.7%。
AFP、吲哚菁绿潴留>10%、输血、Pringle手法、肿瘤直径>3 cm、双侧肿瘤、微血管侵犯、邻近组织侵犯、子结节和肝硬化影响生存。